Alzheimer’s Drug Slows Cognitive Decline; Vaccine-Asthma Link; What Drives Burnout?

Home » Alzheimer’s Drug Slows Cognitive Decline; Vaccine-Asthma Link; What Drives Burnout?
Alzheimer’s Drug Slows Cognitive Decline; Vaccine-Asthma Link; What Drives Burnout?


Note that some links may require subscriptions.

Investigational lecanemab showed a small but significant reduction in cognitive decline in early Alzheimer’s disease in a phase III trial, drug developers Eisai and Biogen said.

Vaccine-related aluminum exposure may be linked with asthma in kids, a preliminary finding that needs further investigation. (Academic Pediatrics)

Florida hospitals cancelled surgeries and transferred patients as Hurricane Ian approaches. (Washington Post)

A Congressional report seen by Reuters estimates the opioid crisis cost the nation $1.5 trillion in 2020 alone.

The FDA said it now will review only a small number of emergency use authorization requests for COVID tests, encouraging developers to pursue authorization through traditional pathways.

The agency also cleared five more batches of Moderna’s updated bivalent booster shots made at a facility in Indiana after it deemed them safe for use. (Reuters)

Can blood proteins predict long COVID? (eBioMedicine)

A global study confirmed that some women may experience a slight, likely temporary increase in their menstrual cycle length after COVID-19 vaccines. (BMJ Medicine)

COVID-19 reduced life expectancy across the Americas and sharpened economic inequities and health disparities, according to a report from the Pan American Health Organization.

Teens’ interest in long-lasting birth control appears to be rising after the Supreme Court overturned Roe v.Wade. (AP)

The FDA’s warning about cooking chicken in NyQuil reportedly led to 7,000 searches on TikTok, as opposed to only five per day before the agency’s statement. (Fox News)

Forensic genetic markers used to identify people in the U.S. criminal justice system may reveal information that compromises medical privacy. (PNAS)

The CellFX stimulation system received FDA approval for an expanded indication to treat sebaceous hyperplasia in patients with Fitzpatrick skin types I-III, Pulse Biosciences announced.

In new industry guidance, the FDA said that artificial intelligence tools that alert on patients likely to develop sepsis should be regulated as devices. (STAT)

What drives physician burnout? These six things, a healthcare consultant said. (Becker’s Hospital Review)

The Biden administration will propose that nutrition labels be placed on the front of food packages instead of the back. (USA Today)

Hospital EmPATH units (emergency psychiatric assessment, treatment, and healing) are moving some patients with mental health crises out of emergency rooms. (Bloomberg)

A Michigan nurse who stole fentanyl and replaced it with saline avoided prison, but was sentenced to 5 years of probation and fined $5,000. (Mlive)

Weightlifting and moderate-to-vigorous aerobic activity were associated with a lower risk of all-cause and cardiovascular disease mortality. (British Journal of Sports Medicine)

Google and Fitbit have launched cloud tools to help hospitals collect and process data from wearable devices. (STAT)

The Democratic Republic of Congo declared an end to the Ebola outbreak in its eastern North Kivu province. (Reuters)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

#Alzheimers #Drug #Slows #Cognitive #Decline #VaccineAsthma #Link #Drives #Burnout



Source link

Leave a Reply

Your email address will not be published.